Evidence map›Paper›PMID 40442618›Full record

ArticleBMC infectious diseases2025

Analysis of rectal carbapenem-resistant Enterobactericeae colonization results first report in Istanbul/Turkiye: Klebsiella pneumoniae co-producing bla

Kamuran Şanlı, Beyza Öncel

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Prevalence and clinical outcomes of Carbapenemase-Producing Enterobacterales (CPE) colonization in patients with solid organ malignancies: a prospective study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Combating Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Multicenter Point-Prevalence Study of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  4. Review
  5. JAC-antimicrobial resistance · 2026
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kamuran ŞanlıUniversity of Health Science, Başakşehir Çam and Sakura City Hospital, Medical Microbiyology, Başakşehir, Istanbul, 34480, Turkey. kamuran67@gmail.com.
Beyza ÖncelUniversity of Health Science, Başakşehir Çam and Sakura City Hospital, Medical Microbiyology, Başakşehir, Istanbul, 34480, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCarbapenemase-Producing Enterobacteriaceae (CPE) are known to be on the rise globally and are a major concern. Rapid screening of at-risk patients and implementation of infection control measures can prevent colonization from becoming a source of infection.

objectiveWe investigated the incidence of carbapenem-resistant Enterobacteriaceae (CRE) colonization, CRE-producing Enterobacteriaceae species, carbapenemase gene types and prevalence in patients subjected to CRE screening tests in rectal swab samples using the CHROMAgar culture method and real-time Polymerase Chain Reaction (PCR) method in a tertiary hospital in Istanbul, Turkiye. In addition, we investigated the effectiveness of diagnosis with PCR and CHROMAgar methods by examining whether meropenem-resistant infection foci developed in patients with CRE colonization from hospitalization to discharge. MATERIALS AND

methodsThis study was conducted retrospectively in the Microbiology Laboratory of 3953 patients at Başakşehir Çam and Sakura City Hospital in Istanbul between January 2021 and December 2023. All data, including CRE colonization screening test results using CHROMAgar and PCR methods, age, gender, requesting clinic, and meropenem-resistant Enterobacteriaceae culture results in infection foci that developed during hospitalization, were obtained from the hospital automated system.

resultsIn all 3953 patients included in the study, CRE colonization was screened by CHROMAgar culture method on rectal swab samples and by real-time PCR method in 500 patients. The mean age of the patients was 42.9 ± 30.1 and 58.1% were male. There was no difference in age and gender distribution between the Upon admission to the hospital and during hospitalization groups (p > 0.05). Rectal CRE colonization was detected in 9.7% of all patients with the CROMAgar method and in 9.2% with the PCR method and in 16.2%. The most statistically significant increase was seen in intensive care units with the CHROMAgar method (p < 0.05). Among Enterobacteriaceae species, Klebsiella pneumoniae (69.6%) was most frequently grown, followed by Escherichia coli (13.7%). There was no statistically significant difference between the groups in terms of CRE growth status and microorganism distribution in rectal swab samples of patients during hospitalization and hospital admission (p > 0.05). Among the CRE genes detected by PCR, single genes were the most common. While OXA-48 positivity was detected in 113 (16.40%) of the patients, bla

conclusionThe CRE colonization rate is high and should be closely monitored with infection control precautions. Although the detection rate of CRE colonization was higher with PCR, the rate of progression to infection in any focus during hospitalization was found to be lower detected with the CHROMAgar method. This situation showed that rapid detection of CRE colonization with PCR, early diagnosis and isolation are important. Klebsiella pneumoniae colonization was the most common causative agent. Co-production of 3 CRE genes (bla

Indexed as

beta-LactamasesCarbapenem-Resistant EnterobacteriaceaeEnterobacteriaceae InfectionsKlebsiella pneumoniaeRectumAdultAgedAnti-Bacterial AgentsBacterial ProteinsCarbapenemsFemaleHumansMaleMiddle AgedPrevalenceRetrospective StudiesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsCarbapenem-resistant EnterobacteriaceaeEnterobacteriaceaeHospitalizationKlebsiella pneumoniaePolymerase chain reaction

Identifiers

PMID40442618
PMCPMC12123834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.